U.S. Construction Stock News

In recent news, Essent Group Ltd. completed US$353.91 million in share repurchases, affirmed a US$0.31 per share quarterly dividend, and reported third quarter 2025 earnings, with basic earnings per share slightly up year-over-year despite a marginal decline in net income and revenue. This combination of capital return activity and stable per-share earnings performance highlights management's ongoing focus on both shareholder value and operational discipline. We'll examine how the company's...

Earlier this month, Douglas Emmett reported lower-than-expected office leasing activity in the previous quarter due to a pronounced slowdown through September, while noting stronger-than-anticipated lease renewals and tenant retention. Despite near-term softness in office leasing, multifamily operations continued to show robust growth, highlighted by a nearly 7% year-over-year rise in same-store cash NOI and plans to add over 1,000 new high-end residential units in Brentwood and...

Curious if CVS Health is a bargain or overpriced right now? You are not alone in wondering whether there is real value hiding in this well-known stock. Shares have surged an impressive 76.3% year-to-date and are up 45.7% over the past year, even as recent weeks brought some turbulence with a -2.4% dip in the last 7 days and a -5.6% move over the last month. Recent headlines have spotlighted CVS Health’s expanding role in healthcare services, such as its bold push into primary care and...

Amprius Technologies, Inc. recently announced the formation of the Amprius Korea Battery Alliance, a collaborative initiative to expand global manufacturing, secure supply chain partners, and support over 2.0 GWh of worldwide contract manufacturing capacity by engaging multiple Korean battery industry leaders. The alliance aims to combine Amprius' silicon anode technology with Korea's manufacturing strengths and strengthen the supply network supporting the electric mobility and clean energy...

In November 2025, Merck announced a quarterly dividend increase and released positive clinical trial results for both WINREVAIR in pulmonary hypertension and enlicitide, its investigational oral PCSK9 inhibitor, alongside updates on a share buyback and the planned acquisition of Cidara Therapeutics for US$9.2 billion. The promising outcomes for WINREVAIR and enlicitide, both targeting significant unmet needs in cardiovascular and pulmonary health, signal Merck's ongoing commitment to...

Biohaven Ltd. ( NYSE:BHVN ) shareholders (or potential shareholders) will be happy to see that the Independent...

Circle Internet Group, Inc. recently reported its third quarter and nine-month financial results and participated in Citi’s 14th Annual FinTech Conference in New York, with CEO Jeremy Allaire addressing industry challenges. The company’s results highlighted a period marked by substantial earnings growth in the latest quarter, but also underscored investor concerns about regulatory pressures, competitive dynamics in the stablecoin market, and insider selling activity. We’ll examine how...

Thermo Fisher Scientific has received FDA 510(k) clearance for its EXENT System, an automated platform designed to enhance the diagnosis of multiple myeloma and related blood disorders by improving result accuracy and clinical workflow efficiency for laboratories in the U.S. and several international markets. This regulatory milestone expands Thermo Fisher’s commercial reach in the diagnostics sector, reflecting how innovation in laboratory automation can influence patient care and clinical...

Copart (CPRT) is set to announce its earnings this Thursday after the market closes. There is heightened interest this time as observers expect revenue growth to be slower than in recent years. See our latest analysis for Copart. Copart’s share price has struggled this year, with a 30-day return of -7.7% leading into earnings and a year-to-date decline of 26.6%, as the market prices in slowing growth expectations. While the pendulum has swung sharply from its recent highs, long-term total...

Energizer Holdings recently reported full-year 2025 earnings results, highlighting a rise in annual sales to US$2.95 billion and a substantial increase in net income compared to the previous year, but quarterly earnings for the fourth quarter missed analyst expectations. While the company pointed to progress from cost-saving initiatives and international growth, its guidance for fiscal 2026 signals uncertainty ahead due to tariff pressures, softer consumer demand, and ongoing supply chain...

The Morning Bull - US Market Morning Update Wednesday, Nov, 19 2025 US stock futures are pointing slightly higher this morning as investors weigh fresh signals from the bond and job markets. The interest paid on 10-year government bonds has slipped to about 4.10%, which often means investors are feeling on edge ahead of new economic reports, especially a key update on job trends. That news comes alongside a bump in people seeking new unemployment benefits, with 232,000 claims registered last...

While not a mind-blowing move, it is good to see that the Genasys Inc. ( NASDAQ:GNSS ) share price has gained 14% in...

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

Most readers would already be aware that Nephros' (NASDAQ:NEPH) stock increased significantly by 36% over the past...

Potential Trex Company, Inc. ( NYSE:TREX ) shareholders may wish to note that the Senior VP & CFO, Prithvi Gandhi...

MaxLinear, Inc. ( NASDAQ:MXL ) shares have had a horrible month, losing 26% after a relatively good period beforehand...

Investors can buy low cost index fund if they want to receive the average market return. But if you invest in...

Some Cadre Holdings, Inc. ( NYSE:CDRE ) shareholders may be a little concerned to see that the President, Brad...

Sono-Tek (NASDAQ:SOTK) has had a great run on the share market with its stock up by a significant 21% over the last...

Precipio, Inc. ( NASDAQ:PRPO ) shares have continued their recent momentum with a 28% gain in the last month alone. The...

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

On November 13, 2025, Iron Mountain announced that it amended its long-standing Credit Agreement, securing $200 million in incremental term loans under conditions consistent with its previous borrowings due in 2031. This move further expands the company’s available funding, positioning Iron Mountain to support its ongoing operational commitments and future growth strategies. To assess how this additional US$200 million in credit may impact Iron Mountain’s growth outlook, let’s examine its...

Kite Realty Group Trust recently raised its quarterly dividend by 7.4% and reported expanding operating margins, reflecting improved efficiency. This increase comes despite a high dividend payout ratio, while the company's strong Piotroski F-Score highlights resilient financial health. We'll explore how the enhanced dividend underscores Kite Realty's commitment to shareholder returns and shapes its investment outlook. The end of cancer? These 29 emerging AI stocks are developing tech that...

If you have ever wondered whether Okta stock is a value gem or just riding the hype, you are in the right place for some clarity. Over the past year, Okta shares have climbed 10.0%, but there have been bumps along the way, including a 4.3% dip this past week and an 8.3% move down over the last month. Recent headlines have focused on Okta’s initiatives in identity and cybersecurity, which have drawn investor interest and sparked renewed debate over the company’s long-term prospects. Strategic...